



As blogging evolved, more and more corporations have begun corporate blogs as a means of engaging the public in dialog. Pharmaceutical companies, representing a highly regulated industry, has been much more reticent and cautious in participating in this medium. Meanwhile, … Continue reading
Anyone in the pharma biz, and particularly the communications biz, is aware that on November 12 and 13, the FDA is holding a Part 15 meeting to gather input regarding the regulation of promotional communications through social media. The meeting … Continue reading